Skip to main content

  • TCT: LAA Closure Holds Up Against Warfarin Long-Term

    • Posted: 11/03/2017
    • Author:

      Nicole Lou, Contributing Writer, MedPage Today, 

    • 2017TCTNews Articles

    Final 5-year data from PREVAIL, pooled with PROTECT AF

    DENVER -- Left atrial appendage (LAA) closure with the Watchman device is comparable to warfarin (Coumadin) long-term for stroke prevention in atrial fibrillation (Afib), according to pooled data from the PREVAIL and PROTECT AF trials.

This site uses cookies. By continuing to browse the site you are agreeing to our use of cookies. Review our Privacy Policy for more details